Search results for: 'counter biologics'

This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent technological developments for molecular marker detection, drug delivery, cancer immunotherapies and radiopharmaceuticals. The TOE also comprises analysis of innovations across cell and gene therapy, antibody and gene editing platfo...

Next-generation fermentation pathways for sustainable fuel production represent an evolving suite of biological and bio-electrochemical processes designed to convert diverse carbon sources, such as CO₂, biomass, waste gases, and organic residues, into liquid fuels. These approaches integrate advances in metabolic engineering, synthetic biology, and...

This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredients mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthet...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprises insights across new developments for antibody-drug conjugates, T-cell engagers, cell and gene therapies, precision immunology and cancer care.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life science...

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...

Near-peer adversary advances in missile lethality and military tension have increased the United States' urgency to advance missile defense systems. In addition, hypersonic missile technology has grown significantly in some nuclear-capable nations during the last few years. Advanced military forces are reaching the limit of what missile technology ...

The ongoing outbreak of coronavirus (COVID-19), first identified in December 2019 in Wuhan—the most populous city in Central China—evolved rapidly to be characterized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Globally, organizations have been monitoring the COVID-19 situation closely and many have already implemented (o...